Ludwig Heumann was born as one of seven children near Nuremberg in 1869. As a child, he was introduced to the healing powers of herbs by his mother. Even after deciding to become a pastor, Ludwig Heumann’s interest in herbal medicine remained.
Intrigued by the ideas and brisk manner of Ludwig Heumann, Dr. Robert Pfaller decided to invest in the pastor’s passion. Due to the high demand for Heumann’s remedies and on the initiative of Robert Pfaller the company Ludwig Heumann & Co. was founded in 1913.
This newly established pharmaceutical company is one of the first to directly address patients in its advertisements; something almost unknown at that time. Nowadays, this approach is known as direct-to-customer advertising (DTC-advertising). Heumann developed and published innovative calendars including health advice and advertisement for Heumann pharmaceuticals. In the 1930s the steadily growing company expands its business by contracting pharmacies to have Heumann products on stock, which turns out to become yet another success story later on.
A second factory was built in Nuremberg in 1935, increasing the capacities to meet the growing demand.
After the complete destruction of the factory during Second World War, it was rebuilt according to the latest standards and production was restarted.
Heumann developed one of the gentlest methods to extract easily volatile and chemically unstable active ingredients from medicinal herbs. Until today, the manufacturing of medicinal teas for therapeutic use is based on this method.
Opening yet another factory in Feucht near Nuremberg also opened up new business areas. The driving force was synthesizing active pharmaceutical ingredients for pharmaceutical products. Successful international marketing of synthetically produced pharmaceutical ingredients and finished products quickly became an important pillar for Heumann Pharma.
In 1989, a line of generic products was introduced. The very first products were: Diclofenac Heumann, Atenolol Heumann and Tamoxifen Heumann.
From synthesizing ingredients up to the final controls of the finished product, everything was done in-house
Despite the takeover in 1989 by G.D. Searle, the Monsanto company responsible for developing and selling pharmaceutical products, Heumann kept its autonomy.
Heumann Pharma became a subsidiary of Pharmacia when Pharmacia & Upjohn fused with Monsanto.
After the acquisition of Pharmacia by Pfizer, Heumann became part of the Pfizer Group in Germany.
Following organizational restructuring, Heumann Pharma GmbH was divided in 2004. Emerging were Heumann PCS GmbH located in Feucht and Heumann Pharma GmbH & Co. KG located in Nuremberg, which continues the marketing and sales activities.
After being founded over 90 years ago, Heumann Pharma becomes part of the Torrent Group, a globally active pharmaceutical company headquartered in Ahmedabad, India.
Until today, this strong connection is key for high-quality pharmaceutical products and affordable offers to customers.
Click here to visit Torrent Pharmaceuticals Limited.
It was decided early on to participate in the bidding for tenders with health insurance companies marking another important milestone in the history of Heumann Pharma. These contracts are the foundation for the dynamic growth of the company and contribute significantly to our success story.
Today, Heumann Pharma is the seventh-largest single company for generic medicines on the German market. Together with HEUNET Pharma it is the fifth-largest pharmaceutical group for generic medicines in Germany (by sales (ApU); Date: MAT 09/2021).
Heumann Pharma ‘s full product range includes products with more than 170 active ingredients.